The Business Times
SUBSCRIBERS

Valeant leads the way in steep price increase of skin drugs

Published Fri, Nov 27, 2015 · 09:50 PM
Share this article.

New York

TWO drugs sold by Valeant Pharmaceuticals International to treat cancer-related skin conditions increased in price by about 1,700 per cent over the last six years, according to a newly published survey that found big increases in the cost of dermatology drugs across the board.

Overall, retail prices of 19 brand-name dermatology drugs from various manufacturers, for …

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Consumer & Healthcare

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here